Dr.Mohan,

I would like to congratulate you for your study. it is a very good study and reproducing similar study in other countries could also help in standardising the number of follow up visits required for the management of diabetes

Congratulations Prof. Mohan about your recent study regarding regular follow-up. At our Diabetes Centre (KLE University), we have very clear evidence of independent status those who were doing very well, and some of these patients miss out the follow-up of their diabetes care. We have observed their uncontrolled diabetes status is proportionate to the length of period they have lost follow-up. Our observations show that these patients end up either with presenting signs of diabetes complications or had already suffered one or two diabetes-related complications. Dr Amena Sadiya's suggestions are quite relevant.

Recevez mes felicitations pour cette etude. Normalement la prise en charge de ces cas de diabete de type 2 se fait par la dietotherapie couplee d une activite physique. Mais le suivi est determinant pour le cas d un diabetique obese ou dans le cas d un diabetique  normoponderal

We have results in the same line in Cameroun.

Congrat for your study. Attached is ours

Happy and blessed new year 2015 in all regards for you and loved ones

Periodic glycemia and HgA1C control are relevanr biomarkers as well as lipoprotein profile  . In Diabetes Mellitus type 2, insulin resistance , visceral obesity, endothelial injury factors like CPR hs, adiponectin,are ethiopathogenic markers of inflammation. Quality of subendothelial plaque is related with  circulating Metaloproteinases 2 and 9. In large studies, % of HgA1C  is very useful in clinical laboratory. 

Our longest continuous use of the artificial pancreas treatment is still underway at 24 years. This is our first young patient, age 5 at commencement, and continues at age 31. A T1DM onset ay age 2, she continues in complete Health without any of the secondary complications not withstanding 30 years of diabetes. Her eyes, kidneys, heart and liver are all without sign of diabetes impact.

As to the first nondiabetic fatty liver disease patient, we have achieved normal liver enzymes in approximately six months and the complete removal of all measurable fat from the liver which has continued for two years.

Dear Prof. Mohan as I remember that I have red a paper for a Russian study  concludes that microangiopathy start 11  years before clinically  overt DM and Hypoglycemic drugs can not stop the progress of the process i.e microangiopathic changes like neuropathy, nephropathy, retinopathy and dermopathy may happen.

Dear All,

Thank you for the numerous responses to my query. I agree with Amena Sadiya that more studies are needed on this to determine the optimum number of visits needed. From our study it suggests that a minimum of 2-3 visits per year itself can help to reduce complications.

With regards,

Dr. V. MOHAN

Thank you Dr. Jali for sharing your experience

Dear Dr. Yessoufou Ganiou,

Thanks for sharing.

With regards,

Dr. V. MOHAN

Regina Wikinski & Dr. Ford Gilbert, Thank you for sharing your experience.

Dear Adil Bashir – It is true that there are some people with type 2 diabetes who have retinopathy and nephropathy even at the time of diagnosis of diabetes. However, this is a very small number. At our centre, we find about 6-7% of the patients may have early retinopathy or nephropathy at the time of diagnosis of diabetes. In the majority of patients, by good control of diabetes the complications can be prevented and this has been very well brought out by the DCCT, UKPDS, kUMAMOTO and other studies.